相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis
Martin Tolar et al.
ALZHEIMERS & DEMENTIA (2020)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
Neuropathological correlates and genetic architecture of microglial activation in elderly human brain
Daniel Felsky et al.
NATURE COMMUNICATIONS (2019)
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Peter T. Nelson et al.
BRAIN (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options
Jeffrey L. Cummings et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Oliver Preische et al.
NATURE MEDICINE (2019)
Aberrant resting-state oscillatory brain activity in Parkinson's disease patients with visual hallucinations: An MEG source-space study
M. Dauwan et al.
NEUROIMAGE-CLINICAL (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
John L. Robinson et al.
BRAIN (2018)
Hypertension-Induced Cerebral Small Vessel Disease Leading to Cognitive Impairment
Yang Liu et al.
CHINESE MEDICAL JOURNAL (2018)
Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies
Yu Gao et al.
CURRENT ALZHEIMER RESEARCH (2018)
Post-Injury Administration of Galantamine Reduces Traumatic Brain Injury Pathology and Improves Outcome
Jing Zhao et al.
JOURNAL OF NEUROTRAUMA (2018)
Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias
Melissa C. Wren et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain
John A. Hey et al.
CNS DRUGS (2018)
Relative survival in patients with dementia with Lewy bodies and Parkinson’s disease dementia
Victoria Larsson et al.
PLoS One (2018)
The antimicrobial protection hypothesis of Alzheimer's disease
Robert D. Moir et al.
ALZHEIMERS & DEMENTIA (2018)
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Harald Hampel et al.
NATURE REVIEWS NEUROLOGY (2018)
Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
Paola Bossu et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease
John A. Hey et al.
CLINICAL PHARMACOKINETICS (2018)
Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study
Javier Olazaran et al.
INTERNATIONAL PSYCHOGERIATRICS (2017)
Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal
Raffaele Nardone et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Impaired cholinergic transmission in patients with Parkinson's disease and olfactory dysfunction
Viviana Versace et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Intensive LDL-cholesterol lowering therapy and neurocognitive function
Maciej Banach et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
Carl F. Eliassen et al.
BRAIN AND BEHAVIOR (2017)
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
Vitaliy Ovod et al.
ALZHEIMERS & DEMENTIA (2017)
Olfactory dysfunction in early Parkinson's disease is associated with short latency afferent inhibition reflecting central cholinergic dysfunction
Eungseok Oh et al.
CLINICAL NEUROPHYSIOLOGY (2017)
Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data
Petr Kocis et al.
CNS DRUGS (2017)
Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential
S. Abushakra et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2017)
Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer's disease
Vincenzo De Luca et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2016)
Homotaurine Effects on Hippocampal Volume Loss and Episodic Memory in Amnestic Mild Cognitive Impairment
Gianfranco Spalletta et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Targeting the Cholinergic System to Develop a Novel Therapy for Huntington's Disease
Gary X. D'Souza et al.
JOURNAL OF HUNTINGTONS DISEASE (2016)
The Epidemiology of Dementia and Alzheimer Disease in Portugal: Estimations of Prevalence and Treatment-Costs
Isabel Santana et al.
ACTA MEDICA PORTUGUESA (2015)
Central cholinergic dysfunction could be associated with oropharyngeal dysphagia in early Parkinson's disease
Kyung Duck Lee et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Homotaurine in Parkinson's disease
Lucia Ricciardi et al.
NEUROLOGICAL SCIENCES (2015)
Clinical Features of Alzheimer Disease With and Without Lewy Bodies
Eun Joo Chung et al.
JAMA NEUROLOGY (2015)
Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis
Gennaro Pagano et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary et al.
ACTA NEUROPATHOLOGICA (2014)
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?
Ada M. Tata et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Honnotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals
Alessandro Martorana et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease
Lynn Rochester et al.
BRAIN (2012)
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Robert D. Bell et al.
NATURE (2012)
Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
David M. Holtzman et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The potential protective effect of tramiprosate (homotaurine) against Alzheimer's disease: a review
Carlo Caltagirone et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
Paul S. Aisen et al.
ARCHIVES OF MEDICAL SCIENCE (2011)
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Yaroslau Compta et al.
BRAIN (2011)
Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: The Alzhemedtm (Tramiprosate) experience
D. Saumier et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Effect of tramiprosate in patients with mild-to-moderate alzheimer's disease: Exploratory analyses of the MRI sub-group of the alphase study
S. Gauthier et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
Joseph L. Price et al.
NEUROBIOLOGY OF AGING (2009)
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
Francine Gervais et al.
NEUROBIOLOGY OF AGING (2007)
Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia
Gustavo C. Roman et al.
NEUROBIOLOGY OF AGING (2006)
A Phase II study targeting amyloid-β with 3APS in mild-to-moderate Alzheimer disease
P. S. Aisen et al.
NEUROLOGY (2006)
A phase 2 study of tramiprosate for cerebral amyloid angiopathy
Steven M. Greenberg et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Immunology and immunotherapy of Alzheimer's disease
HL Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Mild cognitive impairment as a diagnostic entity
RC Petersen
JOURNAL OF INTERNAL MEDICINE (2004)
ApoE genotype accounts for the vast majority of AD risk and AD pathology
J Raber et al.
NEUROBIOLOGY OF AGING (2004)
Apolipoprotein E epsilon 4 in an autopsy series of various dementing disorders
Annette Skraep Nielsen et al.
JOURNAL OF ALZHEIMERS DISEASE (2003)
Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease
JC Morris et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2001)
分享论文
